Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

First-in-class SAM-competitive G9a inhibitor FLAV-27 as a disease-modifying therapy for Alzheimer disease

Molecular Therapy(2025)10.1016/j.ymthe.2025.12.038Source: DataRank Database

First-in-class SAM-competitive G9a inhibitor FLAV-27 as a disease-modifying therapy for Alzheimer disease is a research paper published in Molecular Therapy (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)OA: greenTopics (21)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (39)

David Valle-Garcia,Carla Barbaraci ORCID,Fernando Romero-Becerra,Rohit Kumar Singh,Júlia Jarne-Ferrer

Live enrichment

PubMed:41445192

Generalitat de Catalunya

Grant: 2021 SGR 00357

National Institutes of Health

Grant: R01 DK137056

European Regional Development Fund

Grant: PID2020-119932GB-I00

European Regional Development Fund

Grant: PID2022-1380790B-I00

Argonne National Laboratory

Grant: DE-AC02-06CH11357

Agencia Estatal de Investigación

Grant: MICIU/AEI/10.13039/501100011033

Agència de Gestió d'Ajuts Universitaris i de Recerca

Grant: 2021FISDU 00182

U.S. Department of Energy

Grant: P40 OD010440

U.S. Department of Energy

Grant: DE-AC03-76SF00098

Universitat de Barcelona

Basic Energy Sciences

Ministerio de Ciencia, Innovación y Universidades

Office of Science

European Commission

greenLicense: cc-by-nc-nd

GREENhttps://pmc.ncbi.nlm.nih.gov/articles/PMC13069314/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC13069314/

publisherhttps://api.elsevier.com/content/article/PII:S1525001625010615?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001625010615?httpAccept=text/plain

Fields of Study

Medicine

MeSH Terms

AnimalsMice, TransgenicHumansMiceCaenorhabditis elegansAlzheimer DiseaseDisease Models, AnimalHistone-Lysine N-MethyltransferaseS-AdenosylmethionineHistocompatibility AntigensEnzyme InhibitorsAmyloid beta-Peptides

Keywords

CognitionAlzheimer's diseaseEpigeneticsneuroprotectionTranslationalG9aSmoc1Sam-competitive Inhibitor